I think the SP has taken a beating already, as some may have...

I think the SP has taken a beating already, as some may have expected some delays given MNK's B/S.

Last time we were at sub $1.50 we lost a partner, and most assumed the CHF program was a dud.

We now still have all 4 programs in late stage two passing phase 3 interims and some crucial read outs coming in the next few months.

Chance to accumulate if the belief is that the best is yet to come for MSB, starting with an RMAT designation, positive phase 3 aGVhD read out and positive phase 2b CHF LVAD read out.

RA 52 week read out will signal the opening of that partnership window.

Will likely be bumpy, but I have seen MSB come through much worse and still manage to break $3+ from $1. It's a rollar coaster this ride!

Enjoy the weekend all!